After generating more than $50M in projected medical and pharmacy savings across two Fortune 100 employers, 9amHealth is expanding its AI-driven specialty care platform beyond cardiometabolic care to address the high-cost chronic conditions that account for up to 70% of employer spend.

在为两家《财富》100强企业累计节省超过5000万美元的预计医疗和药房开支后，9amHealth正将其人工智能驱动的专业护理平台从心脑代谢护理扩展到应对占雇主支出高达70%的高成本慢性病。

SAN DIEGO

圣地亚哥

,

，

May 13, 2026

2026年5月13日

/PRNewswire/ --

/PRNewswire/ --

9amHealth

9点健康

, a leading virtual specialty care platform, today announced $26 million in Series B funding led by Define Ventures, with new participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.

，一家领先的虚拟专科护理平台，今天宣布获得了2600万美元的B轮融资，由Define Ventures领投，SemperVirens VC、Catalio Capital Management和NewHealth Ventures新加入投资。

Since its founding, 9amHealth has rapidly emerged as a leader in virtual cardiometabolic care, partnering with large enterprise employers and leading pharmaceutical organizations to support people living with obesity, diabetes, hypertension, and hyperlipidemia. Through its integrated care model, which combines clinical protocols, labs, medication management, and continuous care, the company has delivered significant pharmacy cost savings amid rising demand for .

自成立以来，9amHealth 迅速成为虚拟心脏代谢护理领域的领导者，与大型企业雇主和领先的制药组织合作，为患有肥胖症、糖尿病、高血压和高血脂的人们提供支持。通过其整合的护理模式，结合临床协议、实验室检测、药物管理和持续护理，该公司在需求不断增长的情况下显著降低了药房成本。

GLP-1

GLP-1

therapies while improving engagement and clinical outcomes.

疗法的同时改善参与度和临床结果。

Building on this foundation, 9amHealth has already developed the clinical infrastructure, care delivery model, and technology platform needed to manage complex, high-cost chronic conditions at scale.

基于这一基础，9amHealth 已经开发出临床基础设施、护理交付模型和技术平台，能够大规模管理复杂、高成本的慢性疾病。

The new funding will support continued growth as the company expands its platform to address additional high-cost, specialty-level chronic conditions, which collectively account for up to 70% of employer pharmacy spend.

新资金将支持公司的持续增长，因为公司正在扩展其平台，以应对额外的高成本、专科级别的慢性病，这些疾病总共占雇主药房支出的70%。

These conditions often require ongoing specialty medications, repeat interventions, and coordinated care, which represents the largest and fastest-growing portion of employer healthcare spend.

这些疾病通常需要持续的专科药物治疗、反复干预和协调护理，这代表了雇主医疗支出中最大且增长最快的部分。

'What makes this possible is our ability to combine specialized clinical care with AI-enabled clinical workflows and personalized member experiences that allow us to scale efficiently across complex chronic conditions,'

“使这一切成为可能的是我们能够将专业的临床护理与人工智能赋能的临床工作流程和个性化的会员体验相结合，从而让我们可以高效地在复杂的慢性病领域进行扩展。”

said Frank Westermann, CEO and Co-Founder of 9amHealth.

9amHealth首席执行官兼联合创始人弗兰克·韦斯特曼表示。

'We've already proven this model in cardiometabolic care, and are now extending to a much broader set of high-cost needs.'

“我们已经在心脏代谢护理方面证明了这一模式的有效性，现在正将其扩展到更广泛的高成本需求领域。”

The Series B round was led by

B轮融资由

Lynne O'Keefe, Founder and Managing Partner at Define Ventures

琳恩·奥基夫，Define Ventures创始人兼管理合伙人

, who will join the company's Board of Directors.

，将加入公司董事会。

'We're proud to partner with 9amHealth at this pivotal stage,

“我们很自豪能在这一关键阶段与9amHealth合作，

'

'

said Lynne O'Keefe.

林恩·奥基夫说。

'They've demonstrated strong clinical outcomes and cost savings in one of the fastest-growing categories in healthcare. Their platform has the potential to transform how employers manage their most expensive populations.'

“他们在医疗保健领域增长最快的类别之一中展示了强大的临床效果和成本节约。他们的平台有潜力改变雇主管理最昂贵人群的方式。”

About 9amHealth

关于9amHealth

9amHealth is an AI-enabled virtual specialty care platform focused on managing high-cost chronic conditions at scale. The company partners with employers, health plans, and pharmacy benefit managers to deliver comprehensive, cost-effective medical care for individuals living with obesity, diabetes, hypertension, and dyslipidemia.

9amHealth 是一个启用人工智能的虚拟专科护理平台，专注于大规模管理高成本的慢性疾病。该公司与雇主、健康计划和药品福利管理机构合作，为患有肥胖症、糖尿病、高血压和血脂异常的个人提供全面且经济实惠的医疗服务。

Members receive access to specialized clinicians, including endocrinologists, obesity medicine specialists, and clinical pharmacists, at-home lab testing, prescription medications, and lifestyle support..

会员可以获取专业临床医生的访问权限，包括内分泌科医生、肥胖症医学专家和临床药剂师，以及在家进行的实验室检测、处方药物和生活方式支持。

9amHealth was founded in 2021 and is backed by leading healthcare investors like Define Ventures, SemperVirens VC, 7Wire Ventures, and The Cigna Group Ventures.

9amHealth 成立于2021年，得到了Define Ventures、SemperVirens VC、7Wire Ventures和Cigna Group Ventures等领先医疗保健投资者的支持。

Learn more at

了解更多信息，请访问

www.join9am.com

www.join9am.com

.

。

Download media assets

下载媒体资源

here

这里

.

。

SOURCE 9amHealth

来源 9amHealth

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示